United Therapeutics (UTHR) FCF Margin (2009 - 2026)
United Therapeutics' FCF Margin was 26.25% in Q2 2026, up 10.03 percentage points from 16.22% a year earlier but down 20.14 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) FCF Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, United Therapeutics' FCF Margin was 34.65% through Jun 30, 2026, down 0.15 percentage points year-over-year; for FY2025, it was 32.70%, down 4.86 percentage points from FY2024.
- FCF Margin shows a five-year change of -14.25 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was 37.55% in FY2024 (+5.43 pp), 32.12% in FY2023 (-2.16 pp), 34.28% in FY2022 (+5.95 pp) and 28.32% in FY2021 (-18.63 pp).
- Quarterly FCF Margin has moved between 10.33% (Q2 2023) and 65.79% (Q1 2023) over five years.
- Compared with a year earlier, FCF Margin was higher in three of the last eight quarters, with an average year-over-year change of +0.59 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q1 2022 (a gain of 38.69 percentage points); the worst was Q3 2021 (a drop of 25.36 percentage points).
- Per Business Quant data, UTHR's FCF Margin in the three quarters before Q2 2026 was 46.39% (Q1 2026), 21.93% (Q4 2025) and 43.98% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | United Therapeutics | 24.02 Bn | 13.52 Bn | 683.80 Mn | 26.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.25% |
| Mar 31, 2026 | 46.39% |
| Dec 31, 2025 | 21.93% |
| Sep 30, 2025 | 43.98% |
| Jun 30, 2025 | 16.22% |
| Mar 31, 2025 | 48.63% |
| Dec 31, 2024 | 34.58% |
| Sep 30, 2024 | 40.15% |
| Jun 30, 2024 | 26.17% |
| Mar 31, 2024 | 49.92% |
| Dec 31, 2023 | 11.71% |
| Sep 30, 2023 | 46.03% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 65.79% |
| Dec 31, 2022 | 18.05% |
| Sep 30, 2022 | 36.78% |
| Jun 30, 2022 | 23.56% |
| Mar 31, 2022 | 59.58% |
| Dec 31, 2021 | 25.05% |
| Sep 30, 2021 | 36.50% |
API Access
United Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();